45.7
Cumberland Pharmaceuticals Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
45.9
FY23:
35.7
FY24:
36.5
FY25:
37.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
38.8
FY22:
47.1
FY23:
46.1
FY24:
39.1
FY25:
39.8
Total assets
Change from FY21 to FY25
millions USD
FY21:
84.5
FY22:
92.9
FY23:
81.8
FY24:
75.6
FY25:
76.8
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
19.3
FY22:
28.6
FY23:
28.0
FY24:
31.6
FY25:
36.7
(negative)
Change from FY21 to FY25
millions USD
FY21:
22.6
FY22:
28.4
FY23:
24.5
FY24:
21.4
FY25:
15.5
(positive)
Change from FY21 to FY25
millions USD
FY21:
42.8
FY22:
36.3
FY23:
29.6
FY24:
22.9
FY25:
24.9
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
84.7
FY22:
93.2
FY23:
82.1
FY24:
75.9
FY25:
77.2
All amounts in millions USD